Five Things to Know About the Mylan EpiPen “Settlement” – What It Is and What It Isn’t
Our eyebrows were raised by Mylan’s October 7, 2016 announcement that it had reached a $465 million “settlement” with the United States Department of Justice (DOJ) and “other government agencies” over its Medicaid Drug Rebate obligations for EpiPen. The timing of the announcement was especially eyebrow-raising: close to 5 pm on a Friday afternoon at the start … Read more